2-207613158-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001127395.5(METTL21A):āc.545A>Gā(p.Asn182Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000162 in 1,614,024 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001127395.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
METTL21A | NM_001127395.5 | c.545A>G | p.Asn182Ser | missense_variant | 4/4 | ENST00000411432.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
METTL21A | ENST00000411432.6 | c.545A>G | p.Asn182Ser | missense_variant | 4/4 | 2 | NM_001127395.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152204Hom.: 3 Cov.: 34
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251228Hom.: 1 AF XY: 0.000169 AC XY: 23AN XY: 135768
GnomAD4 exome AF: 0.000144 AC: 210AN: 1461702Hom.: 5 Cov.: 51 AF XY: 0.000113 AC XY: 82AN XY: 727132
GnomAD4 genome AF: 0.000341 AC: 52AN: 152322Hom.: 3 Cov.: 34 AF XY: 0.000336 AC XY: 25AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2024 | The c.545A>G (p.N182S) alteration is located in exon 4 (coding exon 3) of the METTL21A gene. This alteration results from a A to G substitution at nucleotide position 545, causing the asparagine (N) at amino acid position 182 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at